NUEVA PALMIRA, Uruguay–(BUSINESS WIRE)–Cargill inauguró una nueva planta de fertilizantes en su operación de Nueva Palmira, una inversión que refuerza su compromiso con el desarrollo del agro uruguayo y con la mejora continua de los servicios y soluciones que ofrece a sus clientes, acompañando la evolución de una agricultura cada vez más eficiente y orientada al uso responsable de los recursos. “Esta inversión forma parte de nuestra visión de largo plazo para seguir siendo un socio confiable

DENVER–(BUSINESS WIRE)–CPI Card Group Inc. (Nasdaq: PMTS) (“CPI” or the “Company”), a payments technology leader providing a comprehensive range of physical and digital payment solutions, today announced the pricing of a registered underwritten secondary public offering of 2,337,323 shares of the Company’s common stock to be sold by certain stockholders affiliated with Parallel49 Equity (the “selling stockholders”), at a public offering price of $21.50 per share. The underwriters were also gr

TORONTO–(BUSINESS WIRE)–Roots Corporation (the “Company” or “Roots”) (TSX: ROOT) today announced the filing of its management information circular (the “Circular”) and related materials for the special meeting (the “Meeting”) of holders (the “Shareholders”) of common shares (the “Shares”) of Roots to approve the previously-announced plan of arrangement under the Canada Business Corporations Act (the “Arrangement”), pursuant to which Marquee Brands LLC, through its strategic operating partner

NUEVA PALMIRA, Uruguay–(BUSINESS WIRE)–Cargill inaugurated a new fertilizer plant at its Nueva Palmira operation, an investment that reinforces its commitment to the development of Uruguayan agriculture and to the continuous improvement of the services and solutions it offers to its customers, accompanying the evolution of an increasingly efficient agriculture oriented to the responsible use of resources. “This investment is part of our long-term vision to continue being a reliable partner fo

View the video webcast here

SAN DIEGO, Sept. 11, 2026 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real-world solutions, today announced that its pre-recorded presentation for the H.C. Wainwright 28th Annual Global Investment Conference is now available for on-demand viewing here.

The presentation, featuring Sabrina Martucci Johnson, President and Chief Executive Officer of Daré Bioscience, provides an overview of the Company as well as recent corporate and clinical developments.

The on-demand presentation is available for viewing beginning today, September 11, 2026, at 7:00 a.m. ET, and can also be accessed through the Presentations, Events & Webcasts page of the Investors section of the Company’s website (darebioscience.com). The presentation will be accessible for 90 days.

Management will be on-site at the conference, being held September 14–16, 2026, in New York, NY, for one-on-one meetings with investors. For more information, please visit the conference website.

ABOUT DARÉ BIOSCIENCE, INC.

Daré Bioscience (NASDAQ: DARE) is a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real-world solutions. Every innovation Daré Bioscience advances is based in advanced science and backed by rigorous, peer-reviewed research. From contraception to menopause, sexual health to fertility, vaginal health to infectious disease, Daré Bioscience is working to close critical gaps in care using science that serves her needs. For decades, women have been told to “wait it out” or “live with it,” while innovations that could improve their quality of life languish in the regulatory or funding pipeline. With growing awareness around menopause, sexual health, and vaginal health, the conversation is shifting. However, access to proven solutions is lagging. Daré Bioscience is working to change that. Learn more at darebioscience.com.

Contact:
Daré Bioscience Investor Relations
innovations@darebioscience.com 

Source: Daré Bioscience, Inc.

 Transaction in Own Shares

September 10, 2026

• • • • • • • • • • • • • • • •

Shell plc (the ‘Company’) announces that on 10 September 2026 it purchased the following number of Shares for cancellation.

Aggregated information on Shares purchased according to trading venue:

Date of Purchase Number of Shares purchased Highest price paid Lowest price paid Volume weighted average price paid per share Venue Currency
10/09/2026 809,497 £ 35.8000 £ 35.1950 £ 35.4435 LSE GBP
10/09/2026 – – – – Chi-X (CXE) GBP
10/09/2026 – – – – BATS (BXE) GBP
10/09/2026 408,979 € 41.7550 € 41.0700 € 41.3734 XAMS EUR
10/09/2026 – – – – CBOE DXE EUR
10/09/2026 – – – – TQEX EUR

These share purchases form part of the on- and off-market limbs of the Company’s existing share buy-back programme previously announced on 30 July 2026.

In respect of this programme, Goldman Sachs International will make trading decisions in relation to the securities independently of the Company for a period from 30 July 2026 up to and including 23 October 2026.

The on-market limb will be effected within certain pre-set parameters and in accordance with the Company’s general authority to repurchase shares on-market. The off-market limb will be effected in accordance with the Company’s general authority to repurchase shares off-market pursuant to the off-market buyback contract approved by its shareholders and the pre-set parameters set out therein. The programme will be conducted in accordance with Chapter 9 of the UK Listing Rules and Article 5 of the Market Abuse Regulation 596/2014/EU dealing with buy-back programmes (“EU MAR”) and EU MAR as “onshored” into UK law from the end of the Brexit transition period (at 11:00 pm on 31 December 2020)  through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by the Financial Services Act, 2021 and relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time (“UK MAR”) and the Commission Delegated Regulation (EU) 2016/1052 (the “EU MAR Delegated Regulation”) and the EU MAR Delegated Regulation as “onshored” into UK law from the end of the Brexit transition period (at 11:00 pm on 31 December 2020) through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by the Financial Services Act, 2021 and relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time.

In accordance with EU MAR and UK MAR, a breakdown of the individual trades made by Goldman Sachs International on behalf of the Company as a part of the buy-back programme is detailed below.

Enquiries:

Media International: +44 (0) 207 934 5550; U.S. and Canada: https://www.shell.us/about-us/news-and-insights/media/submit-an-inquiry.html

 

Attachment

DALLAS–(BUSINESS WIRE)–Invitation Homes Inc. (NYSE: INVH) (“Invitation Homes,” the “Company,” or “our”), the nation’s premier single-family home leasing and management company, announced today that it has declared a quarterly cash dividend of $0.30 per share payable on shares of its common stock. The dividend will be paid on or before October 16, 2026, to stockholders of record of the Company’s common stock as of the close of business on September 24, 2026. About Invitation Homes Invitation H

SAVANNAH, Ga.–(BUSINESS WIRE)–Citi Trends, Inc. (NASDAQ: CTRN), a leading off-price value retailer of apparel, accessories and home trends primarily for Black families, today announced that Chief Financial Officer Heather Plutino has informed the Company of her decision to step down from her role for personal reasons. Ms. Plutino will continue to serve as Chief Financial Officer while the Company conducts a search for her successor and is committed to ensuring a smooth and orderly transition

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.